Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 4

Sponsor Class

NIH 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 18Lymphoid 15Plasma cell 5Classical hematology 5Breast 4Gastrointestinal 3Sarcoma 2Other neoplasm 2Head & Neck 2Genitourinary 2Dermatologic 2CNS 2Thoracic 1Other solid neoplasm 1

Conditions

Breast Neoplasms 4

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Cytogenetic Analysis × Breast × Clear all
NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
Breast

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

National Cancer Institute (NCI)

Unknown
120 enrolled
Breast

Breast Neoplasms

NCT00082979 2013-08-26

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
60 enrolled
Breast

Breast Neoplasms

NCT00083018 2013-08-26

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡